Press Releases

 Filter by Provider

Salt Lake City, UT, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development, today announced that its Board of Directors has appointed Fred Hassan as Chair, effective October 31, 2026Mr. Hassan arrives with a strong track record of more than four decades in the pharmaceutical industry. He has grown global businesses and led teams that brought multiple medicines through development, regulatory approval and commercial launch. As an example, the severely challenged Schering-Plough returned to sales growth, strong cash flow, and expanded the number of new molecular entities in Phase 3 development from three to eight.

Lifted, an Upwork company, acquires WorkMotion, a leading employer of record (EOR) 

Acquisition expands AI Data Center revenue opportunity 

DURHAM, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today reported financial results for the three and nine months ended September 26, 2026.

CAMBRIDGE, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in three upcoming fireside chats in November:

Wolverine World Wide, Inc. (NYSE: WWW) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of common stock. The dividend is payable on February 1, 2027, to stockholders of record on January 4, 2027. The dividend is equal to the last quarterly dividend and reflects an indicated annual dividend of $0.40 per share.

WARSAW, Ind., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences, held in New York, NY.

CAMBRIDGE, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading provider of growth solutions for property and casualty, or P&C, insurance providers, today announced financial results for the third quarter ended September 30, 2026.

Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced it has completed its acquisition of PurposeMed Inc., the parent company of Freddie, a leading telehealth provider of PrEP and HIV prevention care across the United States and Canada.

AUSTIN, Texas, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ethos (Nasdaq: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced its financial results for the third quarter ended September 30, 2026.

SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (Nasdaq: MWH) (“SOLV”), a leading provider of infrastructure services to the power industry, today announced it has completed the acquisition of ASB Energy Services (“ASB”), a Texas-based contractor specializing in substation foundations, civil construction, and battery energy storage system (BESS) infrastructure.

WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Korsana Biosciences, Inc. (“Korsana” or the “Company”) (Nasdaq: KRSA), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that management will participate in the following upcoming investor conferences.

Dipti Vachani appointed as Chief Executive OfficerSigned multi-year license renewals with Charter and TCLReiterate confidence in long-term $600 million annual revenue outlook

Abivax to Participate in Upcoming Fall Investor Conferences

TARRYTOWN, N.Y., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

VANCOUVER, Wash., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions and one of the largest professional employer organizations (PEO) in the U.S., announced the opening of its BBSI Pittsburgh branch in Canonsburg, Pennsylvania.

BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Monday, November 9, 2026, at 4:30 p.m. ET to report financial results for the third quarter ended September 30, 2026, and to provide a business update.

MIAMI BEACH, Fla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report third quarter 2026 financial results before market open on Friday, November 6, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time.

NEEDHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that on October 31, 2026, the Compensation Committee of Candel's Board of Directors (the Board) granted to 4 new employees, stock options to purchase an aggregate of 107,600 shares of the Company's common stock, with a per share exercise price of $8.33.  

The fragrance icon inspires two new scents, A Thousand Wishes Granted and A Thousand Crystal Wishes, a new solid perfume format and a holiday campaign featuring global fashion icon Valentina Ferrer

Janux Therapeutics, Inc. (Nasdaq: JANX), a clinical-stage biopharmaceutical company developing next-generation immunotherapies, today announced that it will host a virtual event on Monday, November 9, 2026, at 8:30 a.m. ET.

Travere Therapeutics, Inc. (Nasdaq: TVTX) today reported its third quarter 2026 financial results and provided a corporate update.

SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the "Company") today reported results for the quarter ended September 30, 2026.

Advanced Energy Industries, Inc. (Nasdaq: AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, announced financial results for the third quarter ended September 30, 2026.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2026, and raised its full year 2026 revenue guidance.

WATERTOWN, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 85,480 shares of the Company’s common stock to one new employee (the “Inducement Grant”), with the grant made on November 2, 2026 (the “Grant Date”). The Inducement Grant was granted as a material inducement to this individual entering employment with C4T in accordance with Nasdaq Listing Rule 5635(c)(4).

- Keith A. Goldan to retire as CFO and remain with the Company through year-end to support the transition -

VANCOUVER, BC and BOSTON, MA, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced it will report its third quarter 2026 financial results and provide a business update after the close of U.S. financial markets on Monday, November 9, 2026.

NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company’s participation in five investor conferences.

DALLAS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest,” “CSWC” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced its financial results for the second fiscal quarter ended September 30, 2026.

– Total revenue of $83.3 million in 3Q26, an 82% year-over-year increase –

Dr. Shahidi brings extensive drug development experience, regulatory success, and transformative operational expertise to the Board

Atlas Termite & Pest Control in Norman, OK, has unveiled expanded, multi-stage fly eradication services. Combining source identification, bio-foaming treatments, and eco-friendly barriers, the company eliminates fruit, drain, and house fly infestations for local homes and commercial businesses.

LPE Realty LLC, a licensed Florida real estate brokerage, has described how its no-split model works. Its agents keep their full commission and pay a low flat fee per transaction, with current fees published on the company's website.

Proposed amendment would permit voluntary early conversion at the existing conversion price, with all other terms unchanged

Lattice Semiconductor Corporation (Nasdaq: LSCC), the low power programmable and platform firmware leader, announced financial results today for the fiscal third quarter ended October 3, 2026.

ReNew Energy Global Plc (“ReNew” or “the Company”) (Nasdaq: RNW, RNWWW), a leading decarbonization solutions company, today announced its unaudited consolidated IFRS results for Q2 FY27 and H1 FY27.

E*TRADE from Morgan Stanley today released the data from its monthly sector rotation study, which indicates whether clients were net buyers or sellers in each of the 11 core stock market sectors defined by the Global Industry Classification Standard (GICS). These figures, which encompass activity in all US-traded stocks (including OTC) and ADRs, reflect purchases and sales of the individual stocks in each sector, as well as dividend investments and options exercises and assignments.

Lamb Weston Holdings, Inc. (NYSE: LW), a global leader in frozen potato products, today announced its participation in two investor conferences in November 2026.

Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its 2027 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Align Technology’s Research Award Program has funded approximately $4.16 million in research since the program’s inception in 2010.

Cerus Corporation (Nasdaq: CERS) today announced positive topline results from the Phase 3 RedeS (NCT03037164) trial.

AlTi Global, Inc. (NASDAQ: ALTI) (“AlTi”), a leading independent global wealth manager with approximately $96 billion in assets, today announced it will release its financial results for the third quarter of 2026 after the market close on Monday, November 9, 2026. Management will host a conference call and webcast the same day at 5:00pm Eastern Time to provide a business update and discuss the financial results for the quarter.

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced senior management will present and participate in one-on-one meetings at the following upcoming investor conferences in November:

Novacap and the Fonds de solidarité FTQ acquire TA Associates’ stake in AGA

WAYNE, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences:

Milwaukee, WI, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Briggs & Stratton today announced the acquisition of Power Distributors (PD), a premier wholesale distributor of outdoor power equipment parts and engines. This strategic investment unites Briggs & Stratton’s global manufacturing and engineering scale with Power Distributors’ high-performing regional logistics network, creating a fully integrated commercial footprint designed to enhance customer service and drive long-term growth.   

The holiday season is famously busy and expensive. That’s why White Castle is cooking up all-day deals and special gifts to make the coming weeks a little easier. From a 2-for-$4 Double Cheese Slider deal and the return of a fan-favorite seasonal dessert to new gifts that make holiday shopping simple, White Castle is ready to satisfy every craving this season.

CHICAGO, IL / ACCESS Newswire / November 2, 2026 / AELF has completed an $85 million revolving credit facility with Merchants Bank. The financing will be used to enhance the aircraft leasing company's business development goals and expand its mid-life aircraft portfolio.

The social gaming destination will bring 50 physical and mental life-sized mini-games, interactive art, dining, and craft beverages to Connecticut